Trial intelligence / Profile preview

Hemodynamic effects of spinal anesthesia with sufentanil plus bupivacaine versus bupivacaine alone

NL-OMON42723Recruiting

Sponsor
OLVG West
Start
Aug 2017
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of sufentanil and bupivacaine in postoperative pain (2 arms), sponsored by OLVG West. Primary endpoints: Hemodynamic change and Vasopressor use. Started Aug 2017; status: recruiting.

02

Drugs

sufentanilbupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NL-OMON42723.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42723.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call